title: Antiviral or proviral action of mycophenolic acid in hepatitis B infection?
authors.forename: Qiuwei
authors.initials: Q
authors.lastname: Pan
authors.forename: Anneke J
authors.initials: AJ
authors.lastname: van Vuuren
authors.forename: Luc J W
authors.initials: LJ
authors.lastname: van der Laan
authors.forename: Maikel P
authors.initials: MP
authors.lastname: Peppelenbosch
authors.forename: Harry L A
authors.initials: HL
authors.lastname: Janssen
mesh_terms: D005814:Genes, Viral / Q000187:drug effects; D056945:Hep G2 Cells / Q000187:drug effects / Q000502:physiology; D006509:Hepatitis B / Q000188:drug therapy / Q000517:prevention & control*; D006515:Hepatitis B virus / Q000187:drug effects*; D022781:Hepatocytes / Q000187:drug effects; D006801:Humans; D009173:Mycophenolic Acid / Q000009:adverse effects* / Q000494:pharmacology; D020380:Needs Assessment; D016377:Organ Transplantation; D012307:Risk Factors; D014779:Virus Replication / Q000187:drug effects*
chemical_list: D009173:Mycophenolic Acid